Cash and Short Term Investments (Annual) Chart

Historical Cash and Short Term Investments (Annual) Data

View and export this data back to 2016. Start Trial.
Date Value
December 31, 2025 209.86M
December 31, 2024 168.07M
December 31, 2023 285.51M
December 31, 2022 478.93M
December 31, 2021 731.51M
Date Value
December 31, 2020 968.97M
December 31, 2019 336.48M
December 31, 2018 88.25M
December 31, 2017 1.395M
December 31, 2016 9.622M

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Annual) Range, Past 5 Years

View Cash and Short Term Investments (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Annual) Benchmarks

View Cash and Short Term Investments (Annual) Benchmarks
Start Trial
Regeneron Pharmaceuticals, Inc. 8.611B
AbbVie, Inc. 5.257B
Mirum Pharmaceuticals, Inc. 383.33M
ACADIA Pharmaceuticals, Inc. 819.69M
Alnylam Pharmaceuticals, Inc. 2.908B